RemeGen Co., Ltd. (REGMF)
USD 1.5
(0.0%)
USD 1.5
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.25 Billion CNY | 478.77% |
| 2022 | 217.7 Million CNY | 111.82% |
| 2021 | 102.77 Million CNY | -48.01% |
| 2020 | 197.69 Million CNY | 202.45% |
| 2019 | 65.36 Million CNY | 1348.99% |
| 2018 | 4.51 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 329.9 Million USD | 40.98% |
| 2024 Q3 | 353.99 Million USD | 5.61% |
| 2024 Q1 | 235.31 Million USD | 35.01% |
| 2023 Q3 | 115.83 Million USD | -83.49% |
| 2023 Q1 | 45.31 Million USD | -79.18% |
| 2023 FY | 1.25 Billion CNY | 478.77% |
| 2023 Q4 | 179.58 Million USD | 55.03% |
| 2023 Q2 | 701.57 Million CNY | 1448.06% |
| 2022 Q3 | 20.98 Million USD | -76.17% |
| 2022 Q2 | 88.06 Million CNY | 168.87% |
| 2022 Q1 | 32.75 Million USD | -68.13% |
| 2022 FY | 217.7 Million CNY | 111.82% |
| 2022 Q4 | 217.7 Million CNY | 937.49% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 102.77 Million CNY | -48.01% |
| 2021 Q4 | 102.77 Million CNY | 0.0% |
| 2021 Q3 | - USD | -100.0% |
| 2021 Q2 | 125.84 Million CNY | 0.0% |
| 2020 FY | 197.69 Million CNY | 202.45% |
| 2020 Q4 | 197.69 Million CNY | 0.0% |
| 2020 Q2 | 100.8 Million CNY | 0.0% |
| 2019 FY | 65.36 Million CNY | 1348.99% |
| 2019 Q4 | 65.36 Million CNY | 0.0% |
| 2018 FY | 4.51 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -2957.988% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -30467.592% |
| SQZ Biotechnologies Company | 27.47 Million USD | -4486.593% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -2804.994% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -4132.798% |
| Mesoblast Limited | 118.7 Million USD | -961.482% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -132771.616% |
| Genus plc | 233.1 Million USD | -440.533% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -42897.139% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -93677.762% |
| Marizyme, Inc. | 18.71 Million USD | -6631.58% |
| ContraFect Corporation | 2.88 Million USD | -43634.224% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -167897.733% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -929865.975% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -87016.535% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -54070.566% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -22167.663% |
| MultiCell Technologies, Inc. | 202.58 USD | -621968011.363% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -2091.694% |
| EV Biologics, Inc. | 1.49 Million USD | -84193.839% |
| Q BioMed Inc. | 4.1 Million USD | -30556.662% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -3706.48% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -199872.86% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -102474.325% |
| Biomind Labs Inc. | 735.54 Thousand USD | -171199.939% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | -634.491% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -9594.418% |
| Skye Bioscience, Inc. | 4.61 Million USD | -27200.333% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -141779.752% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -890234.092% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -21360.802% |
| IMV Inc. | 28.88 Million USD | -4262.233% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -4898935.732% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -55691.428% |
| GB Sciences, Inc. | 1.75 Million USD | -71518.143% |
| Alpha Cognition Inc. | 1.22 Million USD | -103145.814% |
| HST Global, Inc. | 98.31 Thousand USD | -1281425.443% |
| CSL Limited | 12.18 Billion USD | 89.658% |
| Halberd Corporation | 150 Thousand USD | -839888.667% |
| Enzolytics Inc. | 996.33 Thousand USD | -126361.402% |
| Resverlogix Corp. | 6.49 Million USD | -19311.231% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -263770.785% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -492866.525% |
| argenx SE | 20 Million USD | -6199.915% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -2665.547% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -46416.1% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -12322472.127% |
| Genscript Biotech Corporation | 417.73 Million USD | -201.62% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -627957.084% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -52449.126% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -549412.628% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | -1762.699% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -41535.938% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -350177.446% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -6098.263% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -847494.414% |
| BioStem Technologies, Inc. | 4.71 Million USD | -26643.186% |
| ONE Bio Corp. | 19.71 Million USD | -6290.98% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -503526.56% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -506486.925% |
| Agentix Corp. | 50 Thousand USD | -2519866.0% |
| LadRx Corporation | 33.6 Thousand USD | -3749179.89% |
| Cell Source, Inc. | 9.25 Million USD | -13515.294% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -166519.457% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -166519.457% |
| NovAccess Global Inc. | 2.19 Million USD | -57175.079% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -17714.461% |
| Itoco Inc. | 228.37 Thousand USD | -551611.862% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -597119.102% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -25185.631% |
| Kadimastem Ltd | 891.22 Thousand USD | -141276.374% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -313446.382% |
| CytoDyn Inc. | 30.07 Million USD | -4089.33% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -260074.402% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -358005.37% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -16012.397% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -1028457.551% |
| Rebus Holdings, Inc. | 310 Thousand USD | -406346.129% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -26508.405% |
| International Stem Cell Corporation | 4.17 Million USD | -30057.563% |
| Bioxytran, Inc. | 1.92 Million USD | -65353.662% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -2018682.946% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -57673.534% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -15051.311% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -14576.564% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -80902.894% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -470042.91% |
| Neutra Corp. | 54.15 Thousand USD | -2326480.619% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -68751.53% |
| PureTech Health plc | 25.51 Million USD | -4838.786% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -102820.784% |
| IXICO plc | 472.02 Thousand USD | -266832.544% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -8028.398% |
| Gelesis Holdings, Inc. | 62.26 Million USD | -1923.646% |
| CSL Limited | 12.18 Billion USD | 89.658% |
| Cellectis S.A. | 92.77 Million USD | -1258.084% |